Keyword: Turkey

Turkey is getting its first locally produced mAb via an Iranian biosimilars marker and the $100 million plant it built there.

Novartis is learning about its kickbacks punishment in South Korea as authorities decided to issue a fine of nearly $50 million.

Novartis says it turned up no rule-breaking after investigating of potentially improper payments in Turkey. But an official in Ankara now tells Reuters that the probe is "ongoing."

Novartis has acknowledged that employees in South Korea may have been involved in some rebate shenanigans. But it says an investigation of similar accusations in Turkey uncovered no problems. Now, Novartis considers the matter closed.